Search research articles
Contact Us
Filters
Showing results (11-20 of 28) with videos related to
Page
of 3
Sort By:
Journal of Cancer Survivorship : Research and Practice
|
February 11, 2018
Cardiovascular disease incidence in adolescent and young adult cancer survivors: a retrospective cohort study
Theresa H M Keegan, Lawrence H Kushi, Qian Li, et al.
Clinical Breast Cancer
|
December 17, 2008
A phase II study of imatinib mesylate and capecitabine in metastatic breast cancer: Southwest Oncology Group Study 0338
Helen K Chew, William E Barlow, Kathy Albain, et al.
Investigational New Drugs
|
September 10, 2013
Phase I/II trial of pemetrexed plus nab-paclitaxel in advanced solid tumor patients with emphasis on non-small cell lung cancer
Cheryl Ho, Angela M Davies, Randeep S Sangha, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 8, 2018
Preclinical Development and First-in-Human Imaging of the Integrin α<sub>v</sub>β<sub>6</sub> with [<sup>18</sup>F]α<sub>v</sub>β<sub>6</sub>-Binding Peptide in Metastatic Carcinoma
Sven H Hausner, Richard J Bold, Lina Y Cheuy, et al.
Molecular & Cellular Proteomics : MCP
|
November 25, 2010
High-mannose glycans are elevated during breast cancer progression
Maria Lorna A de Leoz, Lawrence J T Young, Hyun Joo An, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 13, 2010
Prospective multicenter study of the impact of the 21-gene recurrence score assay on medical oncologist and patient adjuvant breast cancer treatment selection
Shelly S Lo, Patricia B Mumby, John Norton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 29, 2014
Endocrine therapy with or without inhibition of epidermal growth factor receptor and human epidermal growth factor receptor 2: a randomized, double-blind, placebo-controlled phase III trial of fulvestrant with or without lapatinib for postmenopausal women with hormone receptor-positive advanced breast cancer-CALGB 40302 (Alliance)
Harold J Burstein, Constance T Cirrincione, William T Barry, et al.
Molecular & Cellular Proteomics : MCP
|
July 19, 2006
A serum glycomics approach to breast cancer biomarkers
Crystal Kirmiz, Bensheng Li, Hyun Joo An, et al.
Bioinformatics (Oxford, England)
|
December 17, 2008
Detecting glycan cancer biomarkers in serum samples using MALDI FT-ICR mass spectrometry data
Donald A Barkauskas, Hyun Joo An, Scott R Kronewitter, et al.
The Oncologist
|
January 24, 2012
Phase II trial of simple oral therapy with capecitabine and cyclophosphamide in patients with metastatic breast cancer: SWOG S0430
Anne F Schott, William E Barlow, Kathy S Albain, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 28) with videos related to
Sort By:
Page
of 3
Journal of Cancer Survivorship : Research and Practice
|
February 11, 2018
Cardiovascular disease incidence in adolescent and young adult cancer survivors: a retrospective cohort study
Theresa H M Keegan, Lawrence H Kushi, Qian Li, et al.
Clinical Breast Cancer
|
December 17, 2008
A phase II study of imatinib mesylate and capecitabine in metastatic breast cancer: Southwest Oncology Group Study 0338
Helen K Chew, William E Barlow, Kathy Albain, et al.
Investigational New Drugs
|
September 10, 2013
Phase I/II trial of pemetrexed plus nab-paclitaxel in advanced solid tumor patients with emphasis on non-small cell lung cancer
Cheryl Ho, Angela M Davies, Randeep S Sangha, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 8, 2018
Preclinical Development and First-in-Human Imaging of the Integrin α<sub>v</sub>β<sub>6</sub> with [<sup>18</sup>F]α<sub>v</sub>β<sub>6</sub>-Binding Peptide in Metastatic Carcinoma
Sven H Hausner, Richard J Bold, Lina Y Cheuy, et al.
Molecular & Cellular Proteomics : MCP
|
November 25, 2010
High-mannose glycans are elevated during breast cancer progression
Maria Lorna A de Leoz, Lawrence J T Young, Hyun Joo An, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 13, 2010
Prospective multicenter study of the impact of the 21-gene recurrence score assay on medical oncologist and patient adjuvant breast cancer treatment selection
Shelly S Lo, Patricia B Mumby, John Norton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 29, 2014
Endocrine therapy with or without inhibition of epidermal growth factor receptor and human epidermal growth factor receptor 2: a randomized, double-blind, placebo-controlled phase III trial of fulvestrant with or without lapatinib for postmenopausal women with hormone receptor-positive advanced breast cancer-CALGB 40302 (Alliance)
Harold J Burstein, Constance T Cirrincione, William T Barry, et al.
Molecular & Cellular Proteomics : MCP
|
July 19, 2006
A serum glycomics approach to breast cancer biomarkers
Crystal Kirmiz, Bensheng Li, Hyun Joo An, et al.
Bioinformatics (Oxford, England)
|
December 17, 2008
Detecting glycan cancer biomarkers in serum samples using MALDI FT-ICR mass spectrometry data
Donald A Barkauskas, Hyun Joo An, Scott R Kronewitter, et al.
The Oncologist
|
January 24, 2012
Phase II trial of simple oral therapy with capecitabine and cyclophosphamide in patients with metastatic breast cancer: SWOG S0430
Anne F Schott, William E Barlow, Kathy S Albain, et al.
Page
of 3